Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated Life Science Investing
Medtronic to announce financial results for its second quarter of fiscal year 2026 Medical Device Investing
Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results Medical Device Investing
Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations Technology Investing
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems Life Science Investing
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Medical Device Investing
Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects Life Science Investing
